One of the most common adverse reactions is antituberculosis drug-induced liver injury (ATB-DILI), which can vary from the asymptomatic elevation of alanine aminotransferase (ALT) to acute hepatic failure, with an incidence rate of 0.8–40% [3]. Here, GPT is linked to Acute hepatic failure.